by Jordana Choucair | Apr 26, 2022 | D.C. News
The White House unveiled new steps aimed at making highly effective COVID-19 treatment pills from Pfizer more widely available. The administration said that it will add 10,000 sites where the Paxlovid pills are available – bringing the total number of sites to 30,000...
by Jordana Choucair | Apr 26, 2022 | D.C. News
The Department of Justice will appeal a federal court ruling on the surprise billing ban that sided with providers by saying the Biden administration’s rule conflicts with the No Surprises Act passed by Congress. Providers sued over the rule because they said...
by Jordana Choucair | Apr 26, 2022 | Life Sciences
The Food and Drug Administration (FDA) on Monday gave its first full approval for a COVID-19 treatment for children under 12. The agency granted approval to the treatment remdesivir, also known as Veklury, made by Gilead Sciences, which has already been approved as a...
by Jordana Choucair | Apr 26, 2022 | Payers
Blue Cross Blue Shield of Michigan (BCBSM) and Honest Medical Group announced they are launching a joint venture that aims to make it easier for providers to transition to value-based care for Medicare patients. The venture aligns with BCBSM’s continued expansion of...
by Jordana Choucair | Apr 26, 2022 | Providers
The American Hospital Association (AHA) released its pandemic hospital costs report, highlighting an 11 percent overall increase—as well as a 20 percent per-patient increase—in total hospital expenses from 2019 through the end of 2021. The report found that, over the...
Recent Comments